Advisornet Financial’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,801
| Closed | -$1.4M | – | 2289 |
|
|
2025
Q4 | $1.4M | Sell |
13,801
-2,757
| -17% | -$221K | 0.07% | 210 |
|
|
2025
Q3 | $906K | Buy |
16,558
+3,115
| +23% | +$156K | 0.05% | 269 |
|
|
2025
Q2 | $714K | Buy |
13,443
+1,412
| +12% | +$71.7K | 0.05% | 299 |
|
|
2025
Q1 | $521K | Buy |
12,031
+1,052
| +10% | +$53.3K | 0.04% | 344 |
|
|
2024
Q4 | $617K | Sell |
10,979
-24
| -0.2% | -$1.49K | 0.05% | 271 |
|
|
2024
Q3 | $750K | Buy |
11,003
+30
| +0.3% | +$1.69K | 0.06% | 260 |
|
|
2024
Q2 | $464K | Buy |
10,973
+671
| +7% | +$36.9K | 0.04% | 317 |
|
|
2024
Q1 | $711K | Buy |
10,302
+1,461
| +17% | +$92.4K | 0.07% | 252 |
|
|
2023
Q4 | $654K | Buy |
8,841
+1,257
| +17% | +$82.4K | 0.06% | 276 |
|
|
2023
Q3 | $517K | Sell |
7,584
-7
| -0.1% | -$594 | 0.05% | 299 |
|
|
2023
Q2 | $713K | Buy |
7,591
+1,135
| +18% | +$88.5K | 0.06% | 253 |
|
|
2023
Q1 | $438K | Buy |
6,456
+4
| +0.1% | +$257 | 0.04% | 317 |
|
|
2022
Q4 | $319K | Buy |
6,452
+1,749
| +37% | +$71.5K | 0.03% | 379 |
|
|
2022
Q3 | $153K | Buy |
4,703
+2,110
| +81% | +$87K | 0.02% | 558 |
|
|
2022
Q2 | $102K | Sell |
2,593
-11,968
| -82% | -$640K | 0.01% | 656 |
|
|
2022
Q1 | $1.02M | Buy |
14,561
+2,708
| +23% | +$198K | 0.06% | 247 |
|
|
2021
Q4 | $923K | Buy |
11,853
+2,777
| +31% | +$245K | 0.06% | 280 |
|
|
2021
Q3 | $866K | Buy |
9,076
+1,640
| +22% | +$173K | 0.06% | 255 |
|
|
2021
Q2 | $924K | Buy |
7,436
+495
| +7% | +$59.1K | 0.06% | 270 |
|
|
2021
Q1 | $915K | Sell |
6,941
-676
| -9% | -$92.5K | 0.07% | 253 |
|
|
2020
Q4 | $1.01M | Sell |
7,617
-669
| -8% | -$80.9K | 0.08% | 218 |
|
|
2020
Q3 | $845K | Sell |
8,286
-2,084
| -20% | -$180K | 0.07% | 240 |
|
|
2020
Q2 | $902K | Sell |
10,370
-5,399
| -34% | -$431K | 0.07% | 236 |
|
|
2020
Q1 | $915K | Buy |
15,769
+2,729
| +21% | +$222K | 0.08% | 204 |
|
|
2019
Q4 | $1.21M | Buy |
13,040
+1,792
| +16% | +$158K | 0.1% | 186 |
|
|
2019
Q3 | $1.02M | Sell |
11,248
-2,564
| -19% | -$292K | 0.09% | 213 |
|
|
2019
Q2 | $1.63M | Sell |
13,812
-4,490
| -25% | -$452K | 0.18% | 123 |
|
|
2019
Q1 | $1.58M | Sell |
18,302
-7,175
| -28% | -$611K | 0.19% | 117 |
|
|
2018
Q4 | $1.61M | Sell |
25,477
-1,185
| -4% | -$81.3K | 0.22% | 98 |
|
|
2018
Q3 | $2.1M | Sell |
26,662
-2,913
| -10% | -$190K | 0.26% | 81 |
|
|
2018
Q2 | $1.77M | Sell |
29,575
-985
| -3% | -$53K | 0.24% | 87 |
|
|
2018
Q1 | $1.23M | Buy |
30,560
+920
| +3% | +$44.9K | 0.17% | 115 |
|
|
2017
Q4 | $1.56M | Buy |
+29,640
| New | +$1.58M | 0.24% | 88 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Advisornet Financial's EXAS Position: Q1 2026 in Review
Advisornet Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,801 shares — an estimated $1.4M sold.
Advisornet Financial first reported a position in EXAS in Q4 2017 and held it in 33 quarters. The position peaked at $2.1M in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Advisornet Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Advisornet Financial sold 13,801 Exact Sciences shares in Q1 2026, an estimated $1.4M.
- Advisornet Financial first reported a position in Exact Sciences in Q4 2017 and held it in 33 quarters.
- Advisornet Financial's Exact Sciences position peaked at $2.1M in Q3 2018.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.